EVI1 impairs myelopoiesis by deregulation of PU.1 function

Cancer Research

Volumn 69, Issue 4, 2009, Pages 1633-1642

  Laricchia Robbio, Leopoldo ^a   Premanand, Kavitha ^a   Rinaldi, Ciro R ^b   Nucifora, Giuseppina ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HELIX LOOP HELIX PROTEIN; MUTANT PROTEIN; PROTEIN C JUN; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR PU 1;

ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; DEREGULATION; DOWN REGULATION; EVI1 GENE; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; MOLECULAR CLONING; MYELODYSPLASTIC SYNDROME; MYELOPOIESIS; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN FUNCTION; ZINC FINGER MOTIF;

3T3 CELLS; ANEMIA; ANIMALS; CELL DIFFERENTIATION; CELL LINE; CHROMATIN; COLONY-FORMING UNITS ASSAY; DNA-BINDING PROTEINS; ERYTHROPOIESIS; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; LUCIFERASES; MICE; MYELODYSPLASTIC SYNDROMES; MYELOPOIESIS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENES; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 60549106713     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-2562     Document Type: Article

References (53)

1. Barjesteh van Waalwijk van Doorn-Khosrovani SC, Erpelinck WL, van Putten PJ, et al. High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients. Blood 2003;101:837-45.
2. Nucifora G, Laricchia-Robbio L, Senyuk V. EVI1 and hematopoietic disorders: history and perspectives. Gene 2006;368:1-11.
3. Russell M, List A, Greenberg P, et al. Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations. Blood 1994;84:1243-8.
4. Suzukawa K, Parganas E, Gajjar A, et al. Identification of a breakpoint cluster region 3′ of the ribophorin I gene at 3q21 associated with the transcriptional activation of the EVI1 gene in acute myelogenous leukemias with inv(3)(q21q26). Blood 1994;84:2681-8.
5. Raza A, Buonamici S, Lisak L, et al. Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 expression. Leuk Res 2004;28:791-803.
6. Morishita K, Parganas E, Matsugi T, Ihle JN. Expression of the Evi-1 zinc finger gene in 32Dcl3 myeloid cells blocks granulocytic differentiation in response to granulocyte colony-stimulating factor. Mol Cell Biol 1992;12:183-9.
7. Senyuk V, Sinha KK, Li D, et al. Repression of RUNX1 activity by EVI1: a new role of EVI1 in leukemogenesis. Cancer Res 2007;67:5658-66.
8. Laricchia-Robbio L, Fazzina R, Li D, et al. Point mutations in two EVI1 Zn fingers abolish EVI1-1 interaction and allow erythroid differentiation of murine bone marrow cells. Mol Cell Biol 2006;26:7658-66.
9. Boyd KE, Xiao YY, Fan K, et al. Sox4 cooperates with Evi1 in AKXD-23 myeloid tumors via transactivation of proviral LTR. Blood 2006;107:733-41.
10. Buonamici S, Li D, Chi Y, et al. EVI1 induces myelodisplastic syndrome in mice. J Clin Inv 2004;114:713-9.
11. Scott EW, Simon MC, Anastasi J, Singh H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 1994;265:1573-7.
12. DeKoter RP, Lee HJ, Singh H. PU.1 regulates expression of the interleukin-7 receptor in lymphoid progenitors. Immunity 2002;16:297-309.
13. Zhang DE, Hohaus S, Voso MT, et al. Function of PU.1 (Spi-1), C/EBP, and AML1 in early myelopoiesis: regulation of multiple myeloid CSF receptor promoters. Curr Top Microbiol Immunol 1996;211:137-47.
14. Anderson KL, Smith KA, Pio F, Torbett BE, Maki RA. Neutrophils deficient in PU.1 do not terminally differentiate or become functionally competent. Blood 1998;92:1576-85.
15. McKercher SR, Torbett BE, Anderson KL, et al. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J 1996;15:5647-58.
16. Chen HM, Zhang P, Voso MT, et al. Neutrophils and monocytes express high levels of PU.1 (Spi-1) but not Spi-B. Blood 1995;85:2918-28.
17. Dahl R, Walsh JC, Lancki D, et al. Regulation of macrophage and neutrophil cell fates by the PU.1:C/ EBPα ratio and granulocyte colony-stimulating factor. Nat Immunol 2003;4:1029-36.
18. Dakic A, Wu L, Nutt SL. Is PU.1 a dosage-sensitive regulator of haemopoietic lineage commitment and leukaemogenesis? Trends Immunol 2007;28:108-14.
19. DeKoter RP, Singh H. Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science 2000;288:1439-41.
20. Singh H, DeKoter RP, Walsh JC. PU.1, a shared transcriptional regulator of lymphoid and myeloid cell fates. Cold Spring Harb Symp Quant Biol 1999;64:13-20.
21. Laricchia-Robbio L, Tamura T, Karpova T, et al. Partner-regulated interaction of IFN regulatory factor 8 with chromatin visualized in live macrophages. Proc Natl Acad Sci U S A 2005;102:14368-73.
22. Nerlov C, Querfurth E, Kulessa H, Graf T. GATA-1 interacts with the myeloid PU.1 transcription factor and represses PU.1-dependent transcription. Blood 2000;95:2543-51.
23. Reddy VA, Iwama A, Iotzova G, et al. Granulocyte inducer C/EBPα inactivates the myeloid master regulator PU.1: possible role in lineage commitment decisions. Blood 2002;100:483-90.
24. Rekhtman N, Radparvar F, Evans T, Skoultchi AI. Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells. Genes Dev 1999;13:1398-411.
25. Petrovick MS, Hiebert SW, Friedman AD, et al. Multiple functional domains of AML1: PU.1 and C/EBPα synergize with different regions of AML1. Mol Cell Biol 1998;18:3915-25.
26. Jousset C, Carron C, Boureux A, et al. A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFR β oncoprotein. EMBO J 1997;16:69-82.
27. Laricchia-Robbio L, Nucifora G. Significant increase of self-renewal in hematopoietic cells after forced expression of EVI1. Blood Cells Mol Dis 2008;40:141-7.
28. Lennartsson A, Garwicz D, Lindmark A, Gullberg U. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites. Gene 2005;356:193-202.
29. Friedman AD, Krieder BL, Venturelli D, Rovera G. Transcriptional regulation of two myeloid-specific genes, myeloperoxidase and lactoferrin, during differentiation of the murine cell line 32Dc13. Blood 1991;78: 2426-32.
30. Gombart AF, Kwok SH, Anderson KL, et al. Regulation of neutrophil and eosinophil secondary granule gene expression by transcription factors C/EBP epsilon and PU.1. Blood 2003;101:3265-73.
31. Wang Y, Barbacioru C, Hyland F, et al. Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays. BMC Genomics 2006;7:59.
32. Zhang DE, Hetherington CJ, Meyers S, et al. CCAAT enhancer-binding protein (C/EBP) and AML1 (CBFα2) synergistically activate the macrophage colony-stimulating factor receptor promoter. Mol Cell Biol 1996;16:1231-40.
33. Nuchprayoon I, Meyers S, Scott LM, Suzow J, Hiebert S, Friedman AD. PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2β/ CBFβ proto-onco-proteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells. Mol Cell Biol 1994;14:5558-68.
34. Miyazaki Y, Setoguchi M, Yoshida S, Higuchi S, Akizuki S, Yamamoto S. The mouse osteopontin gene. Expression in monocytic lineages and complete nucleotide sequence. J Biol Chem 1990;265:14432-38.
35. Xiong H, Zhu C, Li H, et al. Complex formation of the interferon (IFN) consensus sequence-binding protein with IRF-1 is essential for murine macrophage IFN-γ-induced iNOS gene expression. J Biol Chem 2003;278: 2271-7.
36. Anderson KL, Smith KA, Perkin H, et al. PU.1 and the granulocyte- and macrophage colony-stimulating factor receptors play distinct roles in late-stage myeloid cell differentiation. Blood 1999;94:2310-8.
37. Tokita K, Maki K, Mitani K. RUNX1/EVI1, which blocks myeloid differentiation, inhibits CCAAT-enhancer binding protein a function. Cancer Sci 2007;98:1752-7.
38. Wang W, Wang X, Ward AC, Touw IP, Friedman AD. C/EBPα and G-CSF receptor signals cooperate to induce the myeloperoxidase and neutrophil elastase genes. Leukemia 2001;15:779-86.
39. Wang X, Scott E, Sawyers CL, Friedman AD. C/EBPα bypasses granulocyte colony-stimulating factor signals to rapidly induce PU.1 gene expression, stimulate granulocytic differentiation, and limit proliferation in 32Dcl.3 myeloblasts. Blood 1999;94:560-71.
40. Chakraborty S, Senyuk V, Sitailo S, Chi Y, Nucifora G. Interaction of EVI1 with cAMP-responsive element-binding protein-binding protein (CBP) and p300/CBP-associated factor (P/CAF) results in reversible acetylation of EVI1 and in co-localization in nuclear speckles. J Biol Chem 2001;276:44936-43.
41. Ueki U, Zhang L, Haymann MJ. Ski can negatively regulates macrophage differentiation through its interaction with PU.1. Oncogene 2008;27:300-7.
42. Behre G, Whitmarsh AJ, Coghlan MP, et al. c-Jun is a JNK-independent coactivator of the PU.1 transcription factor. J Biol Chem 1999;274:4939-46.
43. Grondin B, Lefrancois M, Tremblay M, et al. c-Jun homodimers can function as a context-specific coactivator. Mol Cell Biol 2007;8:2919-33.
44. Yamada T, Abe M, Higashi T, et al. Lineage switch induced by over-expression of Ets family transcription factor PU.1 in murine erythroleukemia cells. Blood 2001;97:2300-7.
45. Kautz B, Kakar R, David E, Eklund EA. SHP1 protein-tyrosine phosphatase inhibits gp91PHOX and p67PHOX expression by inhibiting interaction of PU.1, IRF1, interferon consensus sequence-binding protein, and CREB-binding protein with homologous Cis elements in the CYBB and NCF2 genes. J Biol Chem 2001;276: 37868-78.
46. Mucenski ML, Taylor BA, Ihle JN, et al. Identification of a common ecotropic viral integration site, Evi-1, in the DNA of AKXD murine myeloid tumors. Mol Cell Biol 1988;8:301-8.
47. Russell M, Thompson F, Spier C, Taetle R. Expression of the EVI1 gene in chronic myelogenous leukemia in blast crisis. Leukemia 1993;7:1654.
48. Rosenbauer F, Tenen DG. Transcription factors in myeloid development: balancing differentiation with transformation. Nat Rev Immunol 2007;7:105-17.
49. Olson MC, Scott EW, Hack AA, et al. PU. 1 is not essential for early myeloid gene expression but is required for terminal myeloid differentiation. Immunity 1995;3:7-14.
50. Tenen DG, Hromas R, Licht JD, Zhang DE. Transcription factors, normal myeloid development, and leukemia. Blood 1997;90:489-519.
51. Lord KA, Abdollahi A, Hoffman-Liebermann B, Liebermann DA. Proto-oncogenes of the fos/jun family of transcription factors are positive regulators of myeloid differentiation. Mol Cell Biol 1993;13:841-51.
52. Zhang P, Behre G, Pan J, et al. Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1. Proc Natl Acad Sci U S A 1999;96:8705-10.
53. Zhang P, Zhang X, Iwama A, et al. PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding. Blood 2000;96:2641-8.